Key Takeaways: GSA released detailed procedural guidance for protecting CUI in nonfederal systems, and a proposed FAR rule would further…
Read More →
On February 12, 2026, Anthropic CEO Dario Amodei told the New York Times that he is “open to the idea” that…
Read More →
On March 5, 2026, the Market Structure Subcommittee of the U.S. Securities and Exchange Commission’s (“SEC”) Investor Advisory Committee (“IAC”) released a…
Read More →
The booming drug rehabilitation industry promises hope to a wide range of people, but it also carries some surprising risks.…
Read More →
Germany’s litigation landscape is being reshaped by the convergence of tighter criminal enforcement, scalable collective redress, and intensified regulatory action…
Read More →
The recoverability of future medical damages is frequently a contested issue in personal injury cases involving alleged permanent injuries. In…
Read More →
When you place a loved one in a nursing home, you do so out of care and responsibility. You are…
Read More →
Ozempic, Wegovy, Mounjaro, and Zepbound have become widely recognized medications in recent years, offering significant benefits for managing type 2…
Read More →
Littler WPI Releases Survey Report on 2025’s Regulatory and Economic Changes on Employers – The first year of the second…
Read More →
Universities and research institutes have long relied on the protections for “fundamental research” under national security laws to enable international…
Read More →